| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in Liferay Enterprise Portal 4.3.6. This affects an unknown function. The manipulation results in cross site scripting. This vulnerability was named CVE-2008-0179. The attack may be performed from remote. There is no available exploit.
Details
A vulnerability, which was classified as problematic, was found in Liferay Enterprise Portal 4.3.6. Affected is an unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in service/impl/UserLocalServiceImpl.java in Liferay Portal 4.3.6 allows remote attackers to inject arbitrary web script or HTML via the User-Agent HTTP header, which is used when composing Forgot Password e-mail messages in HTML format.
The weakness was presented 02/04/2008 as confirmed advisory (CERT.org). The advisory is available at kb.cert.org. This vulnerability is traded as CVE-2008-0179 since 01/09/2008. The exploitability is told to be difficult. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. The technical details are unknown and an exploit is not available. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at SecurityFocus (BID 27550†) and Secunia (SA28742†). See VDB-40822, VDB-40821, VDB-40820 and VDB-40819 for similar entries. If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/09/2008 🔍01/31/2008 🔍
02/01/2008 🔍
02/04/2008 🔍
02/04/2008 🔍
03/16/2015 🔍
07/25/2024 🔍
Sources
Advisory: kb.cert.orgStatus: Confirmed
Confirmation: 🔍
CVE: CVE-2008-0179 (🔍)
GCVE (CVE): GCVE-0-2008-0179
GCVE (VulDB): GCVE-100-40818
CERT: 🔍
SecurityFocus: 27550 - Liferay Enterprise Portal 'User-Agent' HTTP Header Script Injection Vulnerability
Secunia: 28742 - Liferay Portal Multiple Vulnerabilities, Less Critical
See also: 🔍
Entry
Created: 03/16/2015 13:43Updated: 07/25/2024 00:09
Changes: 03/16/2015 13:43 (50), 11/06/2017 08:25 (6), 07/25/2024 00:09 (17)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.